Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171966 | SCV000055146 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000692677 | SCV000820513 | uncertain significance | Dilated cardiomyopathy 1JJ | 2023-09-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 191678). This variant has not been reported in the literature in individuals affected with LAMA4-related conditions. This variant is present in population databases (rs142048329, gnomAD 0.007%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1806 of the LAMA4 protein (p.Gly1806Ser). |
CHEO Genetics Diagnostic Laboratory, |
RCV000769186 | SCV000900562 | uncertain significance | Cardiomyopathy | 2017-02-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000692677 | SCV002794504 | uncertain significance | Dilated cardiomyopathy 1JJ | 2021-09-15 | criteria provided, single submitter | clinical testing |